✦ LIBER ✦

Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor

✍ Scribed by Paul E. Goss

Book ID: 110231670
Publisher: Springer US
Year: 1998
Tongue: English
Weight: 551 KB
Volume: 49
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1006052923468

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

19 - Inhibition of breast cancer tissue

19 - Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole

✍ P.Chr. de Jong; J. van de Ven; J.W.R Nortier; I. Maitimu-Smeele; G.H. Denker; J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Exemestane, a new steroidal aromatase in

Exemestane, a new steroidal aromatase inhibitor of clinical relevance

✍ Paolo Lombardi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Evaluation of plasma and tissue estrogen

Evaluation of plasma and tissue estrogen suppression with third-generation aromatase inhibitors: Of relevance to clinical understanding?

✍ P.E. Lønning; J. Geisler 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Pre-menopausal breast cancer and aromata

Pre-menopausal breast cancer and aromatase inhibitors: treating a new generation of women

✍ O.C. Freedman; S. Verma; M.J. Clemons 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 179 KB

Pre-clinical and clinical evaluation of

Pre-clinical and clinical evaluation of new infant formulas

✍ Cordano, A. 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 385 KB

New generation smallpox vaccines: a revi

New generation smallpox vaccines: a review of preclinical and clinical data

✍ Andrew W. Artenstein 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract The recognition that smallpox is a potential threat agent of bioterrorism has engendered renewed interest in the development of improved vaccines against this pathogen. The purpose of this paper is to review current data regarding novel approaches to smallpox vaccines in comparison with